Endpoints News, the biopharma industry’s leading source for daily news and analysis, today unveiled the 2022 Endpoints 11 – the most promising biotech startup companies of the year.
Born during a boom but virtually shunned on Wall Street today, this group of upstarts is out to defy some tough odds in birthing biotech. This year’s list of Endpoints 11 winners is comprised of companies most likely to make their mark – or go down fighting for a landmark change.
“I’ve been picking top biotech startups for 20 years now, and every year’s class of standouts is different in its own way. This group faces some unusual challenges,” said John Carroll, founder, and editor of Endpoints News. “But they all have substantial resources, top talent, and plans to tackle some of the biggest challenges in biotech. They may not all make it – that doesn’t happen often – but their ambitions define the industry today. And that’s what the Endpoints 11 is all about.”
The 2022 Endpoints 11 winners are:
- Affini-T
- Altos Labs
- Aleteia Therapeutics
- Generate Biomedicines
- Mammoth Biosciences
- Metagenome
- Numero Therapeutics
- Odyssey Therapeutics
- Orna Therapeutics
- Rome Therapeutics
- Versand Bio
The 2022 Endpoints 11 will be hosted live at The 105 in Boston with an open bar and networking beginning at 6 pm ET. At 7 pm ET, Carroll will visit with Nobel Prize laureate and biotech legend Phillip Sharp in an exclusive fireside chat. “Sharp was present at the creation of the biotech industry, which has blossomed into a global endeavor that’s seen investors pile in as startups tackled some of the biggest challenges in drug hunting,” said Carroll.
At 7:30 pm ET, Alessandro Maselli, President & CEO at Catalent, will present the awards alongside Carroll. Attendees will also see exclusive footage of Carroll talking biotech with the teams behind Endpoints 11. The event is sponsored by Catalent, Egnyte, and Precision ADVANCE, the cell & gene therapy collective and will be live-streamed to registrants from 7 to 8:15 pm ET.
This marks John Carroll’s 20th year selecting top private biotechs for special recognition. Registration is open to all biopharma professionals at eleven22.endpts.com. Ticket sales for the live event will close at 4 pm ET today.
